|
24 Feb 2007 |
Satraplatin Shown to Significantly Reduce Risk of Disease Progression in Advanced Hormone-Refractory Prostate Cancer Patients
|
|
24 Feb 2007 |
Oral cancer drug Xeloda receives positive opinion from the European Authorities for the treatment of advanced gastric cancer
|
|
24 Feb 2007 |
SEBIVO(R) (telbivudine) Recommended for Approval in European Union as a new Treatment for Patients with Chronic Hepatitis B
|
|
24 Feb 2007 |
Positive AS1404 trial data presented at ASCO Prostate Cancer Symposium
|
|
24 Feb 2007 |
GTx's ACAPODENE Interim Bone Mineral Density and Lipid Data Highlighted at Press Briefing at Prostate Cancer Symposium of the American Society of Clinical Oncology
|
|
24 Feb 2007 |
Cougar Biotechnology Announces Presentation of Positive Phase I and Phase II Data at ASCO Prostate Cancer Symposium
|
|
23 Feb 2007 |
Phase II Cystic Fibrosis Study Closes Enrollment
|
|
23 Feb 2007 |
Callisto Pharmaceuticals Opens L-Annamycin Phase I Clinical Trial in Pediatric Relapsed or Refractory Acute Leukemia
|
|
23 Feb 2007 |
Hollis-Eden Pharmaceuticals Presents Additional Positive Data with Novel Steroid Hormone in Models of Prostate and Breast Cancer
|
|
23 Feb 2007 |
Valeant Pharmaceuticals Files Investigational New Drug Application for Cesamet(R) in Cancer Chemotherapy-Induced Neuropathic Pain
|
|
23 Feb 2007 |
Auris Medical initiating phase I/II clinical trial with AM-101
|
|
22 Feb 2007 |
Pharmacyclics Receives Refuse to File Letter for Xcytrin
|
|
22 Feb 2007 |
Manhattan Pharmaceuticals, Inc. Completes Enrollment In Phase 2a Study Of Oral Oleoyl-estrone For Obesity
|
|
22 Feb 2007 |
Sosei Announces Progression of SD118 Towards Phase 1 Studies
|
|
22 Feb 2007 |
Allegiance Equity Corporation Announces Positive Results of In Vitro Studies and an Open Label Trial for Relieva(R) in Treating Atopic Dermatitis
|
|
22 Feb 2007 |
Landark study shows important benefits of Seretide(TM) mtreatment for patients with fatal lung disease, COPD
|
|
21 Feb 2007 |
BioMarin Announces Results From Phase 2 Clinical Study of 6R-BH4 in Poorly Controlled Hypertension
|
|
21 Feb 2007 |
Lux Biosciences Initiates LUMINATE Pivotal Clinical Trials of Its Next-Generation Calcineurin Inhibitor, LX211, in Uveitis
|
|
21 Feb 2007 |
Roche and GSK agree on two transactions
|
|
21 Feb 2007 |
Avalon Pharmaceuticals Announces the Initiation of Drug Discovery Program for the MYC Oncoprotein - One of the Most Important and Intractable Cancer Targets
|
|
21 Feb 2007 |
Alteon's Investigational Drug Alagebrium Demonstrates Ability to Improve Functional Membrane Transport in a Rat Model of Chronic Peritoneal Dialysis, Indicating a Potential Role in Kidney Disease
|
|
21 Feb 2007 |
Novacea's ASCENT Phase 2 Trial Published in the Journal of Clinical Oncology
|
|
21 Feb 2007 |
Theravance Announces FDA Acceptance of Telavancin NDA
|
|
21 Feb 2007 |
Hana Biosciences Reports Likely Delay in Launch of Zensana
|
|
20 Feb 2007 |
Basilea Reports Positive Phase III Results for Alitretinoin
|
